News
Scarlet Therapeutics gains funding for blood cell platform
Scarlet Therapeutics – a company focused on developing red blood cell therapeutics – has announced that it has generated seed funding from both Meltwind and Science Creates Ventures.
You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.
Scarlet Therapeutics – a company focused on developing red blood cell therapeutics – has announced that it has generated seed funding from both Meltwind and Science Creates Ventures.